The long-term effects of the Covid-19 infection on cardiac symptoms

Reza Golchin Vafa1,2, Reza Heydarzadeh1,2, Mohammadhossein Rahmani2

  • 1Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.

PubMed

Insights

Long COVID can cause lasting cardiovascular issues, with dyspnea being the most common symptom a year after infection. Hospitalized patients experienced more major adverse cardiac events, highlighting the need for ongoing cardiovascular monitoring post-COVID-19.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) is known to affect multiple organ systems beyond the lungs, including the cardiovascular system.
  • Long-term complications of COVID-19 are increasingly recognized, necessitating further investigation into persistent symptoms.

Purpose of the Study:

  • To assess the prevalence and characteristics of long-term cardiovascular symptoms in patients one year after COVID-19 infection.
  • To identify risk factors associated with persistent cardiovascular issues and major adverse cardiac events (MACE) following COVID-19.

Main Methods:

  • A retrospective cohort study was conducted involving patients from an outpatient cardiovascular clinic in Shiraz, Iran.
  • Data were collected from October 2020 to May 2021, including patient history of COVID-19 at least one year prior, current symptoms (dyspnea, chest pain, fatigue, palpitations), and incidence of MACE.

Main Results:

  • The most frequent long-term cardiovascular symptoms included exertional dyspnea (51.2%), dyspnea at rest (41.6%), fatigue (39%), and chest pain (27.1%).
  • Symptoms were more prevalent in patients who had been hospitalized for COVID-19.
  • The overall incidence of MACE was 6.1% during the 12-month follow-up, with higher rates observed in previously hospitalized patients or those with comorbid conditions.

Conclusions:

  • A significant prevalence of cardiovascular symptoms persists one year after COVID-19 infection, with dyspnea being the most common.
  • Hospitalization for COVID-19 is associated with an increased risk of MACE, underscoring the importance of cardiovascular surveillance in these patients.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
16
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9